<?xml version="1.0" encoding="UTF-8"?>
<ref id="B210">
 <label>210.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Xia</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhu</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lan</surname>
    <given-names>Q</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xu</surname>
    <given-names>W</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wu</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ying</surname>
    <given-names>T</given-names>
   </name>, 
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shi</surname>
    <given-names>Z</given-names>
   </name>, 
   <name name-style="western">
    <surname>Jiang</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lu</surname>
    <given-names>L</given-names>
   </name>
  </person-group>
  <day>11</day>
  <month>2</month>
  <year>2020</year>
  <article-title>Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein</article-title>. 
  <source>Cell Mol Immunol</source> doi:
  <pub-id pub-id-type="doi">10.1038/s41423-020-0374-2</pub-id>.
 </mixed-citation>
</ref>
